PMGC HOLDINGS INC. Increase (Decrease) in Inventories
PMGC HOLDINGS INC. (ELAB) reported Increase (Decrease) in Inventories of $278.91 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-14
- PMGC HOLDINGS INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $164.34K.
- PMGC HOLDINGS INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $114.57K.
- PMGC HOLDINGS INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$23.37K.
- PMGC HOLDINGS INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$101.53K, a 1389.61% decline year-over-year.
- PMGC HOLDINGS INC. increase (decrease) in inventories for fiscal 2025 was -$147.87K, a 136.66% decline from fiscal 2024.
- PMGC HOLDINGS INC. increase (decrease) in inventories for fiscal 2024 was $403.30K, a 51.89% increase from fiscal 2023.
- PMGC HOLDINGS INC. increase (decrease) in inventories for fiscal 2023 was $265.52K, a 282.99% increase from fiscal 2022.
- PMGC HOLDINGS INC. increase (decrease) in inventories for fiscal 2022 was $69.33K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $164.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $278.91K 10-Q · filed 2026-08-14 | $255.54K derived: sum of 3 quarters · filed 2026-08-14 | $154.01K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $114.57K 10-Q · filed 2026-05-15 | $91.20K derived: sum of 2 quarters · filed 2026-05-15 | -$10.33K derived: sum of 3 quarters · filed 2026-05-15 | -$10.33K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$23.37K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$124.90K derived: sum of 2 quarters · filed 2026-03-30 | -$124.90K derived: sum of 3 quarters · filed 2026-08-14 | -$147.87K 10-K · filed 2026-03-30 | |
| 2025-09-30 | -$101.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$101.53K derived: sum of 2 quarters · filed 2026-08-14 | -$124.50K 10-Q · filed 2025-11-14 | -$211.96K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$22.97K 10-Q · filed 2026-08-14 | -$110.42K derived: sum of 3 quarters · filed 2026-08-14 | -$102.55K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$22.97K 10-Q · filed 2026-05-15 | -$110.42K derived: sum of 2 quarters · filed 2026-05-15 | -$102.55K derived: sum of 3 quarters · filed 2026-05-15 | -$69.07K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$87.46K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$79.59K derived: sum of 2 quarters · filed 2026-03-30 | -$46.10K derived: sum of 3 quarters · filed 2026-03-30 | $403.30K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $7.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $41.36K derived: sum of 2 quarters · filed 2025-11-14 | $490.75K 10-Q · filed 2025-11-14 | $487.11K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $33.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $482.88K 10-Q · filed 2025-08-13 | $479.24K derived: sum of 3 quarters · filed 2025-08-13 | $500.69K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $449.40K 10-Q · filed 2025-05-14 | $445.75K derived: sum of 2 quarters · filed 2025-05-14 | $467.20K derived: sum of 3 quarters · filed 2025-05-14 | $631.56K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$3.64K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $17.80K derived: sum of 2 quarters · filed 2025-03-28 | $182.16K derived: sum of 3 quarters · filed 2025-03-28 | $265.52K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $21.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $185.80K derived: sum of 2 quarters · filed 2024-11-14 | $269.16K 10-Q · filed 2024-11-14 | $269.16M 10-Q · filed 2023-12-11 | -$19.53M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $164.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $247.72K 10-Q · filed 2024-08-14 | -$19.55M derived: sum of 3 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $83.36K 10-Q · filed 2024-05-15 | -$19.72M derived: sum of 2 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$19.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $69.33K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $19.87M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |